- •Outcome in the largest series of palliative gynaecological pelvic radiotherapy.
- •Overall 80.4% symptom response rate.
- •Toxicity low: ≥Grade v3 GI 2.2% and urinary 3.8%.
- •1 year OS was 25.1% and the median survival was 5.9 months.
Purchase one-time access:Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
One-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
Early Diagnosis [Internet]. [cited 2022 May 16]. Available from: https://crukcancerintelligence.shinyapps.io/EarlyDiagnosis/.
- Epidemiology of cervical cancer with special focus on India.Int J Womens Health. 2015; 16: 405-414
- Social, demographic and healthcare factors associated with stage at diagnosis of cervical cancer: cross-sectional study in a tertiary hospital in Northern Uganda.BMJ Open. 2016; 6: e007690
- Whole pelvis megavoltage irradiation with single doses of 1000 rad to palliate advanced gynecologic cancers.Int J Radiat Oncol Biol Phys. 1979; 5: 333-338
- Once-monthly radiotherapy for the palliation of pelvic gynecological malignancy.Gynecol Oncol. 1983; 16: 112-116
- 1000 Gy single dose palliation for advanced carcinoma of the cervix or endometrium.Int J Radiat Oncol Biol Phys. 1986; 12: 1947-1950
- 10-Gy single-fraction pelvic irradiation for palliation and life prolongation in patients with cancer of the cervix and corpus uteri.Gynecol Oncol. 2001; 82: 167-171
- Palliation of advanced pelvic malignant disease with large fraction pelvic radiation and misonidazole: final report of RTOG phase I/II study.Int J Radiat Oncol Biol Phys. 1987; 13: 1479-1482
- Phase II study of multiple daily fractionations in the palliation of advanced pelvic malignancies: preliminary report of RTOG 8502.Int J Radiat Oncol Biol Phys. 1989; 17: 659-661
- Effect of rest interval on tumor and normal tissue response–a report of phase III study of accelerated split course palliative radiation for advanced pelvic malignancies (RTOG-8502).Int J Radiat Oncol Biol Phys. 1993; 25: 399-403
- A hypofractionated radiotherapy regimen (0-7-21) for advanced gynaecological cancer patients.Clin Oncol (R Coll Radiol). 2011; 23: 476-481
- Recurrent ovarian cancer. Effective radiotherapeutic palliation after chemotherapy failure.Cancer. 1994; 74: 2979-2983
- Radiotherapy improves the survival of patients with metastatic cervical cancer: a propensity-matched analysis of SEER database.Int J Gynecol Cancer. 2018; 28: 1360-1368
- Palliative pelvic radiotherapy for gynaecologic cancer.J Radiat Oncol. 2012; 1: 239-244
- Fractionated palliative pelvic radiotherapy as an effective modality in the management of recurrent/refractory epithelial ovarian cancers: an institutional experience.J Obstet Gynaecol India. 2017; 67: 126-132
- Association of definitive pelvic radiation therapy with survival among patients with newly diagnosed metastatic cervical cancer.JAMAOncol. 2018; 4: 1288-1291
- Efficacy of radical doses of pelvic radiotherapy for primary tumor treatment in patients with newly diagnosed organ metastatic cervical cancer.Radiat Oncol. 2019; 14: 82
- Haemostatic and antialgic effects of the 25 MV photon beam concentrated dose in the treatment of carcinoma of the cervix.J Surg Oncol. 1987; 34: 133-135
- Local radiation therapy for localized relapsed or refractory ovarian cancer patients with or without symptoms after chemotherapy.Int J Gynecol Cancer. 2002; 2 ([Internet])
- Selective irradiation for the treatment of recurrent ovarian carcinoma involving the vagina or rectum.Gynecol Oncol. 2001; 80: 213-220
- Fractionation and outcomes with palliative radiation therapy.Semin Radiat Oncol. 2000; 10: 191-199
- Cost analysis of selected radiotherapeutic modalities for prostate cancer treatment—czech republic case study for the purposes of hospital based HTA.Healthcare (Basel). 2021; 9: 98
- Variable and fixed costs in NHS radiotherapy; consequences for increasing hypo fractionation.Radiother Oncol. 2022; 166: 180-188
- Hypofractionated radiation leads to more rapid bleeding cessation in women with vaginal bleeding secondary to gynecologic malignancy.Radiat Oncol. 2022; 17: 34
- Short-course palliative radiation therapy leads to excellent bleeding control: a single centre retrospective study.Clin Transl Radiat Oncol. 2018; 22: 40-46
- Monthly palliative pelvic radiotherapy in advanced carcinoma of uterine cervix.J Cancer Res Ther. 2005; 1: 208-212
- Short-course palliative radiotherapy for uterine cervical cancer.Radiat Oncol J. 2013; 31: 216-221
- Radiation therapy for patients with bone metastasis from uterine cervical cancer: its role and optimal radiation regimen for palliative care.Anticancer Res. 2018; 38: 1033-1040
- A retrospective study of rapid symptom response in bleeding gynecologic malignancies with short course palliative radiation therapy: less is more.J Pain Symptom Manage. 2021; 61: 377-383.e2
- Low initial human papilloma viral load implicates worse prognosis in patients with uterine cervical cancer treated with radiotherapy.J Clin Oncol. 2009; 27: 5088-5093
- Clinical significance of HIF-2α immunostaining area in radioresistant cervical cancer.J Gynecol Oncol. 2011; 22: 44-48
- Expression of hypoxic-inducible factor 1alpha predicts metastasis-free survival after radiation therapy alone in stage IIIB cervical squamous cell carcinoma.Int J Radiat Oncol Biol Phys. 2004; 60: 513-521
- Prognostic relevance of carbonic anhydrase-IX in high-risk, early-stage cervical cancer: a Gynecologic Oncology Group study.Gynecol Oncol. 2010; 116: 452-458
- Vascular endothelial growth factor (VEGF) expression is a prognostic factor for radiotherapy outcome in advanced carcinoma of the cervix.Br J Cancer. 2000; 83: 620-625
- Up-regulation of long non-coding RNA CCAT2 correlates with tumor metastasis and poor prognosis in cervical squamous cell cancer patients.Int J Clin Exp Pathol. 2015; 8: 13261-13266